INTERAKSI OBAT PADA PASIEN SINDROM KORONER AKUT DI RSUD KOTA BANJAR

Authors

  • Citra Dewi Salasanti Universitas Bakti Tunas Husada, Indonesia
  • Mochamad Doni Permana Program Studi Farmasi, Fakultas Farmasi, Universitas BTH
  • Keni Idacahyati Program Studi Farmasi, Fakultas Farmasi, Universitas BTH

DOI:

https://doi.org/10.36465/jop.v6i2.1252

Keywords:

Acute Coronary Syndrome, Potential Drug Interaction

Abstract

The prevalence of acute coronary syndrome disease in Indonesia at 2016 reached 36.3% of the total deaths in Indonesia. In some cases of acute coronary syndrome accompanied by comorbidities, in one prescription using several drugs simultaneously to get the expected therapeutic results. However, the concurrent use of these drugs can result in drug related problems that can affect the patient's therapeutic outcome. The purpose of this study was to determine the profile of acute coronary syndrome drug use and to determine the potential for drug interactions in acute coronary syndrome patients in the inpatient installation of Banjar City Hospital. The research method used is observational research with a descriptive approach and data collection is done retrospectively. The sample used was the medical records of patients with acute coronary syndrome who were hospitalized at the Banjar City Hospital in January-December 2021 as many as 50 patients. Sampling method using purposive sampling technique. The data is processed using Microsoft Excel software and then classified based on the severity of the interactions that occur. The results obtained were that the most widely used acute coronary syndrome drugs were the antiplatelet group as much as 43%, after that the nitrate group was 19%, statins were 16%, anticoagulants were 8%, ACE inhibitors were 6%, beta blockers were 5%, CCBs as much as 2%, and anti angina as much as 1%. The number of patients who have the potential to experience drug interactions are 50 patients or 100%. Of all the drugs, there were 321 potential drug interactions, of which 22% were minor severity, 67% moderate severity, and 11% major severity.

ABSTRAK
Penyakit Sindrom Koroner Akut (SKA) menyumbang sebanyak 36,3% dari total kematian di Indonesia. Pasien SKA seringkali memiliki kondisi penyakit penyerta lain, yang mengharuskan pemberian 2 hingga 5 jenis obat dalam mencapai hasil terapi yang diinginkan. Penggunaan obat secara bersamaan dapat menimbulkan interaksi obat yang dapat memengaruhi efektivitas terapi. Penelitian ini bertujuan untuk mengevaluasi interaksi obat pada pasien SKA yang dirawat inap di RSUD Kota Banjar. Penelitian deskriptif observasional retrospektif dilakukan dengan mengamati rekam medis 50 pasien SKA yang dirawat di rumah sakit tersebut dari Januari hingga Desember 2021. Hasil penelitian menunjukkan bahwa semua pasien yang diteliti berisiko mengalami interaksi obat dengan total 321 kejadian potensi interaksi obat. Dari interaksi tersebut, 67% tergolong dalam kategori interaksi obat dengan tingkat keparahan moderat. Dapat disimpulkan bahwa interaksi obat pada semua pasien SKA yang dirawat di RSUD Kota Banjar selama periode tersebut, perpotensi terjadi pada semua pasien dengan lebih dari separuhnya menimbulkan efek yang tidak diinginkan pada tingkat moderat.

References

Aisyah et al. (2022) ‘Kejadian Penyakit Jantung Koroner pada Pasien di RSUD Pasar Rebo’, HIGEIA JOURNAL OF PUBLIC HEALTH RESEARCH AND DEVELOPMENT, 6(4).

Anggriyanto, R. (2014) HASIL PENELITIAN FAKTOR-FAKTOR RESIKO YANG MEMPENGARUHI KEJADIAN SINDROM KORONER AKUT USIA ≤ 45 TAHUN DI POLIKLINIK JANTUNG RUMAH SAKIT ISLAM JAKARTA CEMPAKA PUTIH TAHUN 2014. Jakarta. Available at: https://perpus.fikumj.ac.id/index.php?p=fstream-pdf&fid=793&bid=2577 (Accessed: 26 March 2024).

Berryman, L.Y.P. (2000) ‘Pharmacotherapy Handbook, Second Edition’, In The Annals of Pharmacotherapy, 34(12).

Herdaningsih, S. et al. (2016) ‘Potential of Drug-Drug Interaction in Polypharmacy Prescription: Retrospective Study on a Drugstore in Bandung’, Indonesian Journal of Clinical Pharmacy, 5(4), pp. 288–292. Available at: https://doi.org/10.15416/ijcp.2016.5.4.288.

Kementrian Kesehatan Republik Indonesia (2019) ‘KEPUTUSAN MENTERI KESEHATAN REPUBLIK INDONESIA NOMOR HK.01.07/MENKES/675/2019 TENTANG PEDOMAN NASIONAL PELAYANAN KEDOKTERAN TATA LAKSANA SINDROMA KORONER AKUT’, Kementrian Kesehatan Republik Indonesia [Preprint]. Jakarta: Kementrian Kesehatan Republik Indonesia.

Kurniawati, F. et al. (2021) ‘Kajian Adverse Drug Reactions Terkait Interaksi Obat di Bangsal Rawat Inap Rumah Sakit Akademik UGM’, JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice), 10(4). Available at: https://doi.org/10.22146/jmpf.60228.

Made, N. and Dewi, A.R. (2020) Sasambo Journal of Pharmacy Interaksi Obat Antara Klopidogrel dan Proton Pump Inhibitor (PPI), SJP. Available at: http://jffk.unram.ac.id/index.php/ssp/index.

Muti, A.F. and Chasanah, U. (2016) ‘Evaluasi Rasionalitas Penggunaan Diuretik pada Pasien Gagal Ginjal Kronik yang Dirawat Inap di RSUD Dr. Saiful Anwar Malang’, Sainstech Farma, 9(2), pp. 23–31.

Powers, W.J. et al. (2019) ‘Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American Stroke Association’, Stroke. Lippincott Williams and Wilkins, pp. E344–E418. Available at: https://doi.org/10.1161/STR.0000000000000211.

Rahayu, S. (2018) INTERAKSI ANTAR OBAT PADA PERESEPAN PASIEN RAWAT INAP PEDIATRIK RUMAH SAKIT X DENGAN MENGGUNAKAN APLIKASI MEDSCAPE (Drug Interaction Between The Prescribing Pediatric Inpatients At Hospital X Using Medscape Applications). Available at: www.medscape.com.

Rahmiati, S. and Supadmi, W. (2012) ‘KAJIAN INTERAKSI OBAT ANTIHIPERTENSI PADA PASIEN HEMODIALISIS DI BANGSAL RAWAT INAP RSU PKU MUHAMMADIYAH YOGYAKARTA PERIODE TAHUN 2010’,

Jurnal Ilmiah Kefarmasian, 2(1), pp. 97–110.

Stockley (2008) Stockley’s Drug Interaction. 8th edn. London: Pharmaceutical Press.

Torry, S.R. V., Panda, L. and Ongkowijaya, J. (2014) ‘GAMBARAN FAKTOR RISIKO PENDERITA SINDROM KORONER AKUT’, Jurnal e-CliniC (eCl), 2(1), pp. 1–8.

Wahid, A. et al. (2019) ‘KARAKTERISTIK PASIEN SINDROM KORONER AKUT PADA PASIEN RAWAT INAP RUANG TULIP DI RSUD ULIN BANJARMASIN’, Indonesian Journal for Health Sciences, 3(1), pp. 6–12. Available at: http://journal.umpo.ac.id/index.php/IJHS/.

Wahidah and Harahap, R.A. (2021) ‘PJK (Penyakit Jantung Koroner) dan SKA (Sindrome Koroner Akut) dari Prespektif Epidemiologi’, Afiasi: Jurnal Kesehatan Masyarakat, 6(1), pp. 54–65.

Published

2024-08-10

How to Cite

Salasanti, C. D., Permana, M. D., & Idacahyati, K. (2024). INTERAKSI OBAT PADA PASIEN SINDROM KORONER AKUT DI RSUD KOTA BANJAR. Journal of Pharmacopolium, 6(2). https://doi.org/10.36465/jop.v6i2.1252

Issue

Section

Artikel

Citation Check

Similar Articles

> >> 

You may also start an advanced similarity search for this article.